Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
imatinib (gleevec) (1 trial)
cladribine (leustatin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Mastocytosis (Phase 4)
Mastocytosis, Systemic (Phase 4)
Trials (2 total)
Trial APIs (3 total)